Medicare Enrolled

Dr. Lilit Mnatsakanyan, MD

Neurology · Orange, CA
Practice pattern: Remote Monitoring — Significant remote device monitoring activity
Speaking/Promotional
101 THE CITY DRIVE SOUTH, Orange, CA 92868
7145060381
In practice since 2008 (17 years)
NPI: 1811159197 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mnatsakanyan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mnatsakanyan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mnatsakanyan

Dr. Lilit Mnatsakanyan is a neurology specialist in Orange, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mnatsakanyan performed 2,692 Medicare services across 648 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mnatsakanyan received a total of $8,772 from 15 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mnatsakanyan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 19% volume in CA $8,772 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,692
Medicare services
Top 19% in CA for neurology
648
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~158 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Continuous intraoperative neurophysiology monitoring, remote
Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments.
2,116 $27 $145
Placement of skin electrodes and measurement of stimulated sites on arms and legs
This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs.
158 $39 $205
Electromyography of 2 extremities
A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function.
111 $69 $367
Central motor stimulation test of arms and legs
This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs.
91 $101 $531
VEEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
83 $169 $912
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
33 $43 $255
Video EEG monitoring, 2-12 hours
This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report.
23 $109 $589
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
22 $102 $454
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $44 $430
EEG monitoring, 12-26 hours with review
This procedure involves monitoring brain wave activity for 12 to 26 hours. A healthcare professional reviews the data and provides a report.
12 $117 $694
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
11 $44 $257
EEG monitoring for coma or sleep
This procedure measures brain wave activity to monitor patients who are in a coma or asleep.
11 $49 $257
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,772
Total received (2018-2024)
Avg $1,253/year across 7 years
Top 24% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
47
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,839 (55.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,934 (44.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,244
2023
$321
2022
$692
2021
$18
2020
$29
2019
$226
2018
$6,243

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
NEUROPACE, INC.
$950
SK Life Science, Inc.
$294
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
NEUROPACE, INC.
$6,295
Medtronic USA, Inc.
$837
SK Life Science, Inc.
$294
UCB, Inc.
$264
Catalyst Pharmaceuticals, Inc.
$177
GENZYME CORPORATION
$125
Grifols USA, LLC
$124
Amgen Inc.
$121
CSL Behring
$121
Eisai Inc.
$121
NeuroPace, Inc.
$105
Neurelis, Inc.
$80
Sunovion Pharmaceuticals Inc.
$47
Grifols Shared Services North America, Inc.
$46
NuVasive, Inc.
$16
Top 3 companies account for 84.7% of all-time payments
Associated products mentioned in payments ›
ACTIVA · Aimovig · DISEASE STATE · FYCOMPA · Fintepla · Fycompa · Gamunex-C · Hizentra · KYNMOBI · RNS Neurostimulator Kit · RNS System · VALTOCO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a neurology specialist in Orange?
Compare neurologists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
277
Per 100K population
8.8
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Mnatsakanyan is a remote monitoring specialist, with above-average Medicare volume (top 19% in CA), with speaking/promotional industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Mnatsakanyan experienced with continuous intraoperative neurophysiology monitoring, remote?
Based on Medicare claims data, Dr. Mnatsakanyan performed 2,116 continuous intraoperative neurophysiology monitoring, remote services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mnatsakanyan receive payments from pharmaceutical companies?
Yes. Dr. Mnatsakanyan received a total of $8,772 from 15 companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mnatsakanyan's costs compare to other neurologists in Orange?
Dr. Mnatsakanyan's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mnatsakanyan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →